FOXO1 promotes resistance of Non-Hodgkin lymphomas to anti-CD20-based therapy.
Authors: Zerrouqi A., Pyrzynska B., Dwojak M., Zapala P., Miazek N., Machnicki M.M., Golab J., Winiarska M.
Published in: EACR-AACR-SIC Special Conference 2017: The Challenges of Optimizing Immuno- and Targeted Therapies.
Publication type: conference